United States · Platforms & data · TipRanks

Theriva Biologics Completes Sale of SYN-004 and Related Assets

Published by TipRanks · United States 9 h ago

Theriva Biologics is a diversified clinical-stage company developing therapeutics for cancer and related diseases in areas of high unmet need. Its lead candidate is VCN-01, an…

Read the full article on TipRanks Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.tipranks.com)

Also worth reading

Seeking Alpha

Empire State Realty Trust FFO of $0.20 beats by $0.02, revenue of $193.05M beats by $4.34M

MarketBeat

V2X (NYSE:VVX) Issues Earnings Results

The Motley Fool

Stock Market Today, Nov. 2: Apple Stock Slides Ahead of Earnings, but Its Latest Results Tell a Different Story

MarketWatch

Traders rushing into a leveraged ETF to make a bullish bet on the Nasdaq-100 just got burned

Investing.com

People Inc earnings missed by $8.96, revenue fell short of estimates

CNBC